Suppr超能文献

评估 COVID-19 大流行期间儿童呼吸道感染中的人冠状病毒 OC43 和 SARS-COV-2。

Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.

机构信息

Department of Periodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

J Med Virol. 2022 Apr;94(4):1450-1456. doi: 10.1002/jmv.27460. Epub 2021 Nov 24.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is an overwhelming crisis across the world. Human Coronavirus OC43 (HCoV-OC43) is a Betacoronavirus responsible mostly for mild respiratory symptoms. Since the presentations of HCoV-OC43 and severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) are believed to resemble a lot, the aim of this study was to evaluate the frequency and characteristics of HCoV-OC43 in the current pandemic and the rate of coinfection for the two viruses. One hundred and seventeen patients referred to Children's Medical Center, Tehran, Iran with respiratory symptoms were included. Real-time reverse transcription-polymerase chain reaction (RT-PCR) methods were performed for the detection of HCoV-OC43 and SARS-COV-2. Totally, 23 (20%) had a positive RT-PCR for HCoV-OC43 and 25 (21%) were positive for SARS-COV-2. Two patients (2%) had a positive PCR for both HCoV-OC43 and SARS-COV-2. The two groups showed significant differences in having contact with family members with suspected or confirmed COVID-19 (p = 0.017), fever (p =  0.02), edema (p = 0.036), vomiting (p < 0.001), abdominal complaints (p = 0.005), and myalgia (p = 0.02). The median level of lymphocyte count in patients with HCoV-OC43 was significantly lower than patients with SARS-COV-2 infection (p =  0.039). The same frequency of SARS-COV-2 and HCoV-OC43 was found in children with respiratory symptoms during the COVID-19 pandemic. The rate of coinfection of SARS-COV-2 with HCoV-OC43 in our study was 0.08. Further research into the cocirculation of endemic coronaviruses, such as HCoV-OC43 and SARS-CoV2, in different regions, is highly recommended. Attempts to determine the geographic distribution and recruit more flexible test panel designs are also highly recommended.

摘要

2019 年冠状病毒病(COVID-19)大流行是全球范围内的一场压倒性危机。人类冠状病毒 OC43(HCoV-OC43)是一种贝塔冠状病毒,主要引起轻微的呼吸道症状。由于 HCoV-OC43 和严重急性呼吸综合征冠状病毒 2(SARS-COV-2)的表现被认为非常相似,因此本研究旨在评估 HCoV-OC43 在当前大流行中的频率和特征,以及两种病毒的合并感染率。伊朗德黑兰儿童医学中心收治了 117 例有呼吸道症状的患者。采用实时逆转录聚合酶链反应(RT-PCR)方法检测 HCoV-OC43 和 SARS-COV-2。总共 23 例(20%)HCoV-OC43 RT-PCR 阳性,25 例(21%)SARS-COV-2 RT-PCR 阳性。2 例患者(2%)HCoV-OC43 和 SARS-COV-2 的 PCR 均为阳性。两组在与有疑似或确诊 COVID-19 的家庭成员接触(p=0.017)、发热(p=0.02)、水肿(p=0.036)、呕吐(p<0.001)、腹部不适(p=0.005)和肌痛(p=0.02)方面有显著差异。HCoV-OC43 感染患者的淋巴细胞计数中位数明显低于 SARS-COV-2 感染患者(p=0.039)。在 COVID-19 大流行期间,有呼吸道症状的儿童中 SARS-COV-2 和 HCoV-OC43 的检出率相同。本研究中 SARS-COV-2 与 HCoV-OC43 的合并感染率为 0.08。强烈建议进一步研究地方性冠状病毒(如 HCoV-OC43 和 SARS-CoV2)在不同地区的共同流行情况。还强烈建议尝试确定地理分布并招募更灵活的测试面板设计。

相似文献

4
Coronavirus HKU1 and other coronavirus infections in Hong Kong.
J Clin Microbiol. 2006 Jun;44(6):2063-71. doi: 10.1128/JCM.02614-05.
6
Epidemiology of endemic human coronavirus infection during the COVID-19 pandemic.
J Infect Chemother. 2024 May;30(5):400-405. doi: 10.1016/j.jiac.2023.11.012. Epub 2023 Nov 17.
9
Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2.
J Virol Methods. 2022 Jan;299:114317. doi: 10.1016/j.jviromet.2021.114317. Epub 2021 Oct 9.

引用本文的文献

1
Reply to Masters: Recombinant coronavirus balances biosafety and benefit.
Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2416109121. doi: 10.1073/pnas.2416109121. Epub 2024 Oct 21.
2
Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2310421121. doi: 10.1073/pnas.2310421121. Epub 2024 Jul 8.
4
Co-infection of SARS-CoV-2 with human coronavirus OC43 in a patient with underlying lung disease: A case report.
J Assoc Med Microbiol Infect Dis Can. 2023 Sep 18;8(2):150-153. doi: 10.3138/jammi-2022-0030. eCollection 2023 Sep.
6
Surveillance of endemic coronaviruses during the COVID-19 pandemic in Iran, 2021-2022.
Influenza Other Respir Viruses. 2023 Mar 24;17(3):e13128. doi: 10.1111/irv.13128. eCollection 2023 Mar.
9
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19.
medRxiv. 2022 Sep 26:2022.09.25.22280335. doi: 10.1101/2022.09.25.22280335.
10
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.
Front Microbiol. 2022 Aug 31;13:974205. doi: 10.3389/fmicb.2022.974205. eCollection 2022.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
Clinical Evaluation of Conventional Human Coronavirus Infection in Adults.
Jpn J Infect Dis. 2022 Mar 24;75(2):121-126. doi: 10.7883/yoken.JJID.2021.250. Epub 2021 Aug 31.
3
Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic.
J Infect Public Health. 2021 Sep;14(9):1186-1190. doi: 10.1016/j.jiph.2021.08.004. Epub 2021 Aug 8.
5
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19.
J Clin Virol. 2021 Jun;139:104847. doi: 10.1016/j.jcv.2021.104847. Epub 2021 Apr 24.
6
Bibliography of published COVID-19 in children literature.
Arch Dis Child. 2022 Feb;107(2):168-172. doi: 10.1136/archdischild-2021-321751. Epub 2021 May 6.
7
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.
Immunity. 2021 May 11;54(5):1055-1065.e5. doi: 10.1016/j.immuni.2021.04.006. Epub 2021 Apr 13.
9
Analysis and forecasting of global real time RT-PCR primers and probes for SARS-CoV-2.
Sci Rep. 2021 Apr 26;11(1):8988. doi: 10.1038/s41598-021-88532-w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验